Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Roberto Spina , Chris Anthony , David WM Muller , et al Added: 3 years ago
Transcatheter aortic valve replacement (TAVR) with either the balloonexpandable Edwards SAPIEN XT valve (Edwards Lifesciences, Irvine, California), or the self-expandable CoreValve prosthesis (Medtronic, Minneapolis, Minnesota) has become the established therapeutic modality for severe aortic valve stenosis in patients who are not deemed suitable for surgical intervention due to excessively high… View more
Author(s): Pavel Overtchouk , Thomas Modine Added: 3 years ago
This article aims to provide an updated comparative review, addressing the respective strengths and weaknesses of different alternative transcatheter aortic valve implantation (TAVI) approaches. The transfemoral (TF) access is favoured by international guidelines on TAVI because of its reported superiority to the transthoracic approach.1–3 In spite of the progress in miniaturisation of new… View more
Author(s): Eduardo A Arias , Amit Bhan , Zhan Lim , et al Added: 3 years ago
During the past decade, transcatheter aortic valve implantation (TAVI) has revolutionised the interventional treatment of aortic stenosis (AS).1 It has rapidly evolved from a treatment used on a compassionate basis for inoperable patients to being the standard of care in high-risk AS.2,3 In that cohort it has proven to be non-inferior to surgical aortic valve replacement (SAVR) in terms of… View more
Author(s): Michael Teitelbaum , Rafail Kotronias , Luciano A Sposato , et al Added: 3 years ago
Since its introduction in 2002, transcatheter aortic valve implantation (TAVI) has provided an alternative to surgical aortic valve replacement (SAVR) in patients considered inoperable or either at high or intermediate risk for SAVR.1 However, one of the most feared complications of TAVI are cerebrovascular accidents (CVA) including stroke or transient ischaemic attack. Further to this, TAVI… View more
Author(s): Michael Lauterbach , Bruno Sontag , Karl-Eugen Hauptmann Added: 3 years ago
Over the past nine years, since the first transcatheter aortic valve implantation (TAVI) by Cribier et al.1 in France in 2002, this new technique has enthralled cardiologists all over the world. With the deployment of TAVI – about 40,000 procedures have been carried out worldwide so far – cardiologists intruded into the previously unshared domain of surgical aortic valve replacement. Albeit… View more
Author(s): John Phineas O’Donnell , Crochan J O’Sullivan Added: 3 years ago
The demand for replacing degenerated bioprosthetic valves (BPVs) is steadily rising owing to the increasing burden of heart disease, ageing populations, advances in surgical intervention and limited durability of current-generation surgical BPVs. The issue is exacerbated by the increasing trend of surgical BPV replacement, especially in younger patients who are likely to require future… View more